Evaluation of CD137 and CD137L Transcript Levels and the Serum sCD137 in Immune-mediated Polyneuropathy | ||
| Iranian Journal of Immunology | ||
| دوره 20، شماره 1، بهار 2023، صفحه 104-113 اصل مقاله (1.84 M) | ||
| نوع مقاله: Original Article | ||
| شناسه دیجیتال (DOI): 10.22034/iji.2023.96695.2453 | ||
| نویسندگان | ||
| Shirin Torkestani1؛ Alireza Zamani1؛ Mehrdokht Mazdeh2؛ Elahe Talebi-Ghane3؛ Ghodratoallah Roshanaie3؛ Mohammad Mahdi Eftekharian* 1، 4 | ||
| 1Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. | ||
| 2Department of Neurology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. | ||
| 3Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences. | ||
| 4Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. | ||
| چکیده | ||
| Background: Abnormal humoral and cellular immune responses have been reported in immune-mediated polyneuropathies. CD137, as a costimulatory molecule and a TNF receptor superfamily member, has been demonstrated to have a key role in the pathogenesis of many autoimmune as well as inflammatory disorders. Objective: To evaluate the transcripts levels of CD137, its ligand (CD137L), and the serum levels of soluble CD137 (sCD137) in patients with immune-mediated polyneuropathy. Methods: A total of 45 patients and 46 sex and age-matched healthy individuals were enrolled in the study. CD137 and CD137L transcript levels were assessed by the Real-Time PCR, and the serum level of sCD137 was measured using the ELISA technique. The Bayesian regression model was used for statistical analysis at the 0.05 significance level in R 4.1.0 statistical environment. Results: Transcript levels of the CD137 and CD137L were higher in polyneuropathy patients in comparison with the healthy subjects (P=0.006 for both). Conversely, the mean level of sCD137 was significantly lower in the sera of patients compared to the controls (P<0.001). Conclusion: Our findings point to the possible role of CD137 and CD137L in immune-mediated polyneuropathy pathogenesis. More investigations are required to clarify the exact contributions of the mentioned molecules to the pathogenesis of immune-mediated polyneuropathies. | ||
| کلیدواژهها | ||
| CD137 Antigen؛ Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Tumor Necrosis Factor Receptor Superfamily؛ sCD137 | ||
| مراجع | ||
|
| ||
|
آمار تعداد مشاهده مقاله: 1,111 تعداد دریافت فایل اصل مقاله: 861 |
||